Related Experiment Video
Updated: Mar 22, 2026

Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors
Published on: January 20, 2023
Hsp90 Inhibitors in Parasitic Nematodes: Prospects and Challenges
Eileen Devaney1, Victoria Gillan
1Institute of Biodiversity, Comparative Medicine and Animal Health, University of Glasgow, Garscube Estate, Bearsden Road, Glasgow G61 1QH, UK. eileen.devaney@glasgow.ac.uk.
Abstract:
Hsp90 inhibitors are well characterized in relation to their effects in a variety of tumors, with several inhibitors in various phases of clinical development. In recent years, the same inhibitor classes have been tested for efficacy in other systems, such as Alzheimer's disease and a variety of infectious disease models, including fungal and parasitic targets. In this article we discuss the repurposing of Hsp90 inhibitors for parasitic disease with a focus on parasitic nematode infections. We summarize the data that indicate that Hsp90 is functionally diverse in different nematode species and we discuss the challenges and prospects for developing these inhibitors as next generation chemotherapeutic tools.
Insights
Heat shock protein 90 (Hsp90) inhibitors show promise for treating parasitic nematode infections. Research indicates Hsp90
Area of Science:
- Parasitology and drug discovery
- Molecular biology and drug repurposing
Background:
- Heat shock protein 90 (Hsp90) inhibitors are established cancer therapeutics.
- Hsp90 inhibitors are being explored for neurodegenerative and infectious diseases.
Purpose of the Study:
- To discuss the repurposing of Hsp90 inhibitors for treating parasitic nematode infections.
- To explore the potential of Hsp90 as a therapeutic target in nematodes.
Main Methods:
- Review of existing data on Hsp90 inhibitors in parasitic diseases.
- Analysis of Hsp90 functional diversity across nematode species.
Main Results:
- Hsp90 exhibits functional diversity in different nematode species.
- Hsp90 inhibitors demonstrate potential efficacy against parasitic nematodes.
Conclusions:
- Hsp90 inhibitors represent a promising avenue for novel chemotherapeutic strategies against nematode infections.
- Further research is needed to overcome challenges and develop Hsp90 inhibitors for nematode disease treatment.
More Related Videos
12:40Cultivation of Heligmosomoides Polygyrus: An Immunomodulatory Nematode Parasite and its Secreted Products
Published on: April 6, 2015
09:13Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
Published on: November 22, 2024
Related Concept Videos
Anthelminthic Agents
Fungal Phylum Microsporidia